Perioperative Cognitive Protection - Cognitive Exercise and Cognitive Reserve (The Neurobics Trial)
NCT02230605 is an interventional trial sponsored by Ohio State University. As of 18 Nov 2026, it is completed. It studies Delirium. The registry lists an enrollment of 322 participants at 1 site in 1 country. The registry lists a start date of 31 Jul 2015 and a primary completion date of 20 May 2019.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT02230605 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | Ohio State University |
| Enrollment | 322 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Delirium |
| Start | 31 Jul 2015 |
| Primary completion | 20 May 2019 |
| Study completion | 20 Aug 2019 |
| Last update posted | 11 Sept 2019 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Michelle L Humeidan, MD,PhD
Ohio State University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Ohio State University Wexner Medical Center
Columbus
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT02230605
Each answer restates registry values shown on this page.
What is NCT02230605?
NCT02230605 is an interventional trial sponsored by Ohio State University. It studies Delirium.
Who leads NCT02230605?
The registry names Michelle L Humeidan, MD,PhD (principal investigator, Ohio State University) as the overall official.
Where does NCT02230605 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT02230605 end?
The registry lists a primary completion date of 20 May 2019 and a study completion date of 20 Aug 2019. The sponsor last updated the record on 11 Sept 2019.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.